Detalles de la búsqueda
1.
2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons.
Cancer Immunol Immunother
; 65(6): 663-75, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034232
2.
Enhanced Antitumor Immune Response in 2'-5' Oligoadenylate Synthetase-Like 1- (OASL1-) Deficient Mice upon Cisplatin Chemotherapy and Radiotherapy.
J Immunol Res
; 2019: 7596786, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31049360
3.
Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer.
Immunol Res
; 67(6): 469-477, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900802
4.
Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 25(3): 498-509, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30462267
5.
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Oncotarget
; 8(69): 113345-113359, 2017 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29371915
6.
Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating Chemicals.
PLoS One
; 11(9): e0161899, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27589392
7.
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Neurosci Lett
; 628: 78-84, 2016 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297771
Resultados
1 -
7
de 7
1
Próxima >
>>